Zyomed Corp.
USPTO PatentsView assignee record - 10 granted patents across 4 technology areas, recorded in grant years 2016–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Zyomed ranks #27,926 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 4 technology areas.
- #27,926
- of 49,997 US assignees by volume
- 34th percentile
- by Innovation Score (30.4/100)
- 36.4
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R27926 · US Corporation #27,926 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 10 grants
- MID-PACK #27,926/49,997
- PHOTO-FINISH botek Präzisionsbohr…
- CPC-NARROW A61B · 4 areas
- INNOV-THIN 30.4/100
- CLAIMS-DENSE 36.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: botek Präzisionsbohrtechnik GmbH (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Zyomed’s 30.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Zyomed
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Zyomed · this assignee 30
Zyomed · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Zyomed's Innovation Score is 30.4/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Zyomed?
Each dot is one of Zyomed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Zyomed’s own 36.4 claims/patent is ABOVE the 12.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Zyomed's grants concentrate
Zyomed Corp. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (7 grants) versus a trough of 3 in 2017. By volume, Zyomed sits between Zodiac Seats UK Limited and eBay Korea Co. Ltd..
Who files at Zyomed's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Zodiac Seats UK
Zodiac Seats UK Limited
10 patents
- Zoneplow Reactor
ZonePlow Reactor Technologies, LLC
10 patents
- Zumobi
Zumobi, LLC
10 patents
- Zydus Lifesciences
Zydus Lifesciences Limited
10 patents
- botek Präzisionsb…
botek Präzisionsbohrtechnik GmbH
10 patents
- d light design
d.light design, Inc.
10 patents
- e l f Cosmetics
e.l.f. Cosmetics, Inc.
10 patents
- ebay Korea
eBay Korea Co. Ltd.
10 patents
- Zyomed ◀
Zyomed Corp.
10 patents
What this shows Zyomed holds 10 patents at rank #27,913, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Zyomed
By rank, the assignees closest to #27,913 in granted patent volume.
- Zodiac Seats UK Limited #27,909 · 10 patents
- ZonePlow Reactor Technologies, LLC #27,910 · 10 patents
- Zumobi, LLC #27,911 · 10 patents
- Zydus Lifesciences Limited #27,912 · 10 patents
- botek Präzisionsbohrtechnik GmbH #27,914 · 10 patents
- d.light design, Inc. #27,915 · 10 patents
- e.l.f. Cosmetics, Inc. #27,916 · 10 patents
- eBay Korea Co. Ltd. #27,917 · 10 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Zyomed's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Zyomed's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 34th percentile higher than 34% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 7 | 70.0% |
| 2017 | 3 | 30.0% |
Which technologies does Zyomed Corp. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Zyomed Corp.'s patent record in context - here's where to go next.
- Zyomed Corp.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #27,926 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Zyomed Corp. against Zodiac Seats UK Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.